Genmab A/S (GMAB)
27.95
-0.77
(-2.68%)
USD |
NASDAQ |
May 02, 10:18
Genmab Price: 27.95 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 28.05 | 29.00 | 27.97 | 28.72 | 820834.0 |
Apr 30, 2024 | 27.94 | 28.40 | 27.66 | 27.69 | 933126.0 |
Apr 29, 2024 | 28.01 | 28.65 | 28.01 | 28.57 | 593112.0 |
Apr 26, 2024 | 28.09 | 28.18 | 27.90 | 28.15 | 339610.0 |
Apr 25, 2024 | 27.66 | 27.80 | 27.43 | 27.46 | 436367.0 |
Apr 24, 2024 | 28.75 | 28.76 | 28.09 | 28.47 | 456129.0 |
Apr 23, 2024 | 28.76 | 29.04 | 28.54 | 28.56 | 560041.0 |
Apr 22, 2024 | 28.85 | 29.21 | 28.72 | 28.97 | 452366.0 |
Apr 19, 2024 | 28.47 | 28.81 | 28.45 | 28.70 | 361029.0 |
Apr 18, 2024 | 28.46 | 28.62 | 28.29 | 28.33 | 243953.0 |
Apr 17, 2024 | 28.78 | 28.84 | 28.44 | 28.53 | 358638.0 |
Apr 16, 2024 | 29.06 | 29.61 | 28.77 | 29.43 | 342404.0 |
Apr 15, 2024 | 29.36 | 29.67 | 29.26 | 29.51 | 544079.0 |
Apr 12, 2024 | 29.76 | 29.79 | 29.15 | 29.26 | 413219.0 |
Apr 11, 2024 | 30.03 | 30.11 | 29.42 | 29.74 | 327641.0 |
Apr 10, 2024 | 29.57 | 30.13 | 29.54 | 29.95 | 375459.0 |
Apr 09, 2024 | 29.72 | 30.00 | 29.63 | 29.97 | 385110.0 |
Apr 08, 2024 | 29.82 | 29.94 | 29.67 | 29.86 | 222159.0 |
Apr 05, 2024 | 29.79 | 29.89 | 29.60 | 29.76 | 237451.0 |
Apr 04, 2024 | 30.32 | 30.50 | 29.63 | 29.65 | 517564.0 |
Apr 03, 2024 | 29.35 | 29.68 | 29.17 | 29.30 | 782247.0 |
Apr 02, 2024 | 29.90 | 30.31 | 29.75 | 29.96 | 281668.0 |
Apr 01, 2024 | 29.91 | 30.34 | 29.70 | 30.27 | 362347.0 |
Mar 28, 2024 | 30.47 | 30.56 | 29.84 | 29.91 | 361406.0 |
Mar 27, 2024 | 30.50 | 30.63 | 30.11 | 30.63 | 319427.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
16.37
Minimum
May 13 2019
48.72
Maximum
Sep 03 2021
33.44
Average
35.26
Median
Jul 28 2020
Price Benchmarks
Ascendis Pharma A/S | 142.44 |
Novo Nordisk A/S | 126.15 |
Galecto Inc | 0.69 |
Evaxion Biotech AS | 4.06 |
IO Biotech Inc | 1.59 |
Price Related Metrics
PE Ratio | 29.05 |
PS Ratio | 7.701 |
Price to Book Value | 3.886 |
Price to Free Cash Flow | 18.12 |
Earnings Yield | 3.44% |
Market Cap | 18.24B |
Operating PE Ratio | 23.82 |
Normalized PE Ratio | 26.85 |